Brooklyn Immunotherapeutics Inc (NASDAQ:BTX)

Delayed Data
As of Nov 26
 -0.51 / -7.55%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Brooklyn Immunotherapeutics Inc have a median target of 20.00, with a high estimate of 20.00 and a low estimate of 20.00. The median estimate represents a +223.36% increase from the last price of 6.19.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Brooklyn Immunotherapeutics Inc. This rating has held steady since October, when it was upgraded from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 94.71%
Growthannually 37.50%


Growthquarterly --
Growthannually 468.61%
Key to the earnings and sales forecast charts.